Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: increment
- PDF / 4,250,632 Bytes
- 10 Pages / 595.276 x 790.866 pts Page_size
- 84 Downloads / 201 Views
DIAGNOSTIC NEURORADIOLOGY
Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters Yae Won Park 1 & Sung Soo Ahn 1 Jinyuan Zhou 4 & Seung-Koo Lee 1
&
Eui Hyun Kim 2 & Seok-Gu Kang 2 & Jong Hee Chang 2 & Se Hoon Kim 3 &
Received: 4 July 2020 / Accepted: 26 August 2020 # Springer-Verlag GmbH Germany, part of Springer Nature 2020
Abstract Purpose To evaluate the incremental value of amide proton transfer (APT) imaging to diffusion tensor imaging (DTI), dynamic susceptibility contrast (DSC) imaging, and dynamic contrast-enhanced (DCE) imaging in differentiating recurrent diffuse gliomas (World Health Organization grade II-IV) from treatment-induced change after concurrent chemoradiotherapy or radiotherapy. Methods This study included 36 patients (25 patients with recurrent gliomas and 11 with treatment-induced changes) with post-treatment gliomas. The mean values of apparent diffusion coefficient (ADC), fractional anisotropy (FA), normalized cerebral blood volume (nCBV), normalized cerebral blood flow, volume transfer constant, rate transfer coefficient, extravascular extracellular volume fraction, plasma volume fraction, and APT asymmetry index were assessed. Independent quantitative parameters were investigated to predict recurrent glioma using multivariable logistic regression. The incremental value of APT signal to other parameters was assessed by the increase of the area under the curve, net reclassification index, and integrated discrimination improvement. Results Univariable analysis showed that lower ADC (p = 0.018), higher FA (p = 0.031), higher nCBV (p = 0.021), and higher APT signal (p = 0.009) were associated with recurrent gliomas. In multivariable logistic regression, the diagnostic performance of the model with ADC, FA, and nCBV significantly increased when APT signal was added, with areas under the curve of 0.87 and 0.92, respectively (net reclassification index of 0.77 and integrated discrimination improvement of 0.13). Conclusion APT imaging may be a useful imaging biomarker that adds value to DTI, DCE, and DSC parameters for distinguishing between recurrent gliomas and treatment-induced changes. Keywords Amides . Chemoradiotherapy . Glioma . Magnetic resonance imaging Electronic supplementary material The online version of this article (https://doi.org/10.1007/s00234-020-02542-5) contains supplementary material, which is available to authorized users. * Sung Soo Ahn [email protected] 1
Department of Radiology and Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea
2
Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea
3
Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
4
Division of MRI Research, Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Introduction Disting
Data Loading...
